Mohammad Razaq

1.6k total citations · 1 hit paper
22 papers, 760 citations indexed

About

Mohammad Razaq is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammad Razaq has authored 22 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammad Razaq's work include Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and Photodynamic Therapy Research Studies (3 papers). Mohammad Razaq is often cited by papers focused on Extracellular vesicles in disease (4 papers), MicroRNA in disease regulation (4 papers) and Photodynamic Therapy Research Studies (3 papers). Mohammad Razaq collaborates with scholars based in United States, United Kingdom and Japan. Mohammad Razaq's co-authors include Rajagopal Ramesh, Akhil Srivastava, Narsireddy Amreddy, Anupama Munshi, Meghna Mehta, Rebaz Ahmed, Yan D. Zhao, Mahendran Chinnappan, Nilesh Vasan and Frank E. Mott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mohammad Razaq

21 papers receiving 744 citations

Hit Papers

Phase 1/2a, open‐label, multicenter study of RM‐1929 phot... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Razaq United States 12 372 259 227 165 147 22 760
Lingyun Xia China 14 286 0.8× 129 0.5× 153 0.7× 81 0.5× 33 0.2× 33 711
Jae Hee Lee South Korea 17 278 0.7× 123 0.5× 56 0.2× 137 0.8× 115 0.8× 43 888
Xiaohui Huang China 12 187 0.5× 165 0.6× 76 0.3× 146 0.9× 45 0.3× 40 633
Kanwaldeep Singh Canada 14 222 0.6× 96 0.4× 100 0.4× 90 0.5× 39 0.3× 23 771
Susana Torres‐Martínez Spain 12 191 0.5× 116 0.4× 129 0.6× 122 0.7× 58 0.4× 23 479
Zeyu Xiao China 17 198 0.5× 83 0.3× 93 0.4× 117 0.7× 295 2.0× 46 826
Hongwei Liu China 15 440 1.2× 89 0.3× 311 1.4× 117 0.7× 105 0.7× 31 795
Yogesh T. Patel United States 12 202 0.5× 117 0.5× 52 0.2× 99 0.6× 43 0.3× 29 760
Angela L. Nocera United States 17 492 1.3× 51 0.2× 232 1.0× 137 0.8× 70 0.5× 30 907

Countries citing papers authored by Mohammad Razaq

Since Specialization
Citations

This map shows the geographic impact of Mohammad Razaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Razaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Razaq more than expected).

Fields of papers citing papers by Mohammad Razaq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Razaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Razaq. The network helps show where Mohammad Razaq may publish in the future.

Co-authorship network of co-authors of Mohammad Razaq

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Razaq. A scholar is included among the top collaborators of Mohammad Razaq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Razaq. Mohammad Razaq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cognetti, David M., Jennifer M. Johnson, Joseph Curry, et al.. (2021). Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma. Head & Neck. 43(12). 3875–3887. 120 indexed citations breakdown →
3.
Krempl, Greg A., et al.. (2021). Merkel cell carcinoma: treatment and outcomes over a 10‐year period at a high‐volume academic center. International Journal of Dermatology. 61(5). 558–563. 1 indexed citations
4.
Guenette, Jeffrey P., Nicole G. Chau, Cyrus Sayehli, et al.. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer. 126(17). 3972–3981. 37 indexed citations
5.
Chinnappan, Mahendran, Akhil Srivastava, Narsireddy Amreddy, et al.. (2020). Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Letters. 486. 18–28. 88 indexed citations
6.
Srivastava, Akhil, Narsireddy Amreddy, Mahendran Chinnappan, et al.. (2020). Progress in extracellular vesicle biology and their application in cancer medicine. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(4). e1621–e1621. 48 indexed citations
7.
Temel, Jennifer S., Jeff A. Sloan, Tyler Zemla, et al.. (2020). Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. Journal of Palliative Medicine. 23(7). 922–929. 41 indexed citations
8.
9.
Cognetti, David M., Jennifer M. Johnson, Joseph Curry, et al.. (2019). Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).. Journal of Clinical Oncology. 37(15_suppl). 6014–6014. 23 indexed citations
10.
Bauman, Julie E., Jonathan Harris, Ravindra Uppaluri, et al.. (2019). NRG-HN003: Phase I and expansion cohort study of adjuvant cisplatin, intensity-modulated radiation therapy (IMRT), and MK-3475 (Pembrolizumab) in high-risk head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 37(15_suppl). 6023–6023. 4 indexed citations
12.
Srivastava, Akhil, Narsireddy Amreddy, Mohammad Razaq, et al.. (2018). Exosomes as Theranostics for Lung Cancer. Advances in cancer research. 1–33. 57 indexed citations
13.
Gillenwater, Ann M., David M. Cognetti, Jennifer M. Johnson, et al.. (2018). RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.. Journal of Clinical Oncology. 36(15_suppl). 6039–6039. 23 indexed citations
14.
Mukherjee, Sarbajit, et al.. (2018). Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. American Journal of Therapeutics. 25(3). e394–e396. 2 indexed citations
15.
Machiorlatti, Michael, et al.. (2017). Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution’s 12-year Experience. Anticancer Research. 37(9). 5019–5025. 9 indexed citations
16.
Srivastava, Akhil, Narsireddy Amreddy, Anish Babu, et al.. (2016). Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Scientific Reports. 6(1). 38541–38541. 157 indexed citations
17.
Tanaka, Wesley & Mohammad Razaq. (2015). Aromatase Inhibitors and Osteoporosis - Risk, Prevention and Treatment Review. 3(3). 1 indexed citations
18.
Razaq, Mohammad, et al.. (2007). Use of Hydromorphone (Dilaudid) and Morphine for Patients With Hepatic and Renal Impairment. American Journal of Therapeutics. 14(4). 414–416. 15 indexed citations
19.
Razaq, Mohammad, et al.. (2004). Cat Scratch Disease Mimicking Richter's Syndrome in a Patient with Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 46(3). 443–445. 3 indexed citations
20.
Razaq, Mohammad, et al.. (2004). A Case of Risperidone-Induced Hypothermia. American Journal of Therapeutics. 11(3). 229–230. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026